Reference entry · hGH fragment analog
AOD-9604
Also known as: hGH fragment 176-191 · lipolytic fragment analog
- Class
- hGH fragment analog
- Size
- 16 amino acids (fragment region)
- Primary targets (literature)
- Lipid metabolism literature (preclinical)
- Regulatory context
- Not FDA-approved. Often discussed alongside metabolic peptides but with a thinner formal evidence base.
Overview
AOD-9604 is marketed as a fragment of human growth hormone associated with lipolytic research interest. Published literature is sparse relative to incretin peptides, and catalog identity verification is essential.
Mechanism in research literature
Preclinical literature explores adipose-tissue and lipid-metabolism endpoints in animal models without the human trial depth of GLP-1 agonists.
Common research focus areas
- Rodent lipolysis and body-composition models
- Fragment identity vs. full-length hGH
- Sparse clinical bibliography
- Catalog purity and sequence confirmation
Full literature roundup
Read the cited research summary
An hGH fragment analog with lipolytic research interest. What preclinical literature reports — and where the evidence gaps are.
AOD-9604 research roundup · 5 minEvaluate catalog material
- COA literacy — read batch documentation before comparing vendors.
- Peptide identity testing — why sequence confirmation matters beyond purity %.
- How we vet sources — our score methodology for recommended vendors.